Network origin in Paul Keogh first degree
Entity | Entity type | Industry | |
---|---|---|---|
25
| Subsidiary | Pharmaceuticals: Major | 25 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Paul Keogh via their personal network
Company | Sector | Related people | Main position |
---|---|---|---|
RECKITT BENCKISER GROUP PLC | Household/Personal Care | Director/Board Member Director/Board Member Corporate Secretary General Counsel | |
CENTOGENE N.V. | Miscellaneous Commercial Services | Chairman Director/Board Member Investor Relations Contact | |
TAKEDA PHARMACEUTICAL COMPANY LIMITED | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member | |
Galderma Pharma SA
Galderma Pharma SA Pharmaceuticals: MajorHealth Technology Galderma Pharma SA discovers, develops, and markets therapeutic, corrective, and aesthetic solutions. It offers drugs, medical dermatology solutions, and therapeutic skin care products for treating hair, nail, and skin diseases. The company was founded in 1981 and is headquartered in Lausanne, Switzerland. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member | |
Biotechnology Innovation Organization
Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
Bayer Pharma AG
Bayer Pharma AG Pharmaceuticals: MajorHealth Technology Bayer Pharma AG engages in the development and production of prescription drugs for the treatment of cardiovascular diseases and women's illnesses, as well as special therapy in the areas of oncology, hematology, and ophthalmology. It also offers medical equipment used in diagnostic imaging with applications in the field of radiology. The company was founded on March 9, 1965 and is headquartered in Berlin, Germany. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
Shire Pharmaceuticals, Inc.
Shire Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Shire Pharmaceuticals, Inc. manufactures pharmaceutical products. The company offers solutions for attention deficit & hyperactivity disorder, human genetic therapies, gastrointestinal, and renal diseases. The company was founded in 1986 and is headquartered in Wayne, PA | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
AMGEN INC. | Pharmaceuticals: Major | Director of Finance/CFO Corporate Officer/Principal | |
BAXTER INTERNATIONAL INC. | Medical Specialties | Director/Board Member Director/Board Member | |
VBI VACCINES INC. | Biotechnology | Chairman Director/Board Member | |
Galderma Holding SA
Galderma Holding SA Pharmaceuticals: MajorHealth Technology Galderma Holding SA owns shares and interest of manufacturers and distributors of dermatological and skin care products. The company is headquartered in La Tour-de-Peilz, Swtzerland. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member | |
Proactiv Skin Health Ltd.
Proactiv Skin Health Ltd. Miscellaneous Commercial ServicesCommercial Services Founded in 1997, Proactiv Skin Health Ltd. is a part of Guthy-Renker Partners, Inc. that provides sales and support services. The company is based in London, UK. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
BAXALTA INC | Biotechnology | Director/Board Member Director/Board Member | |
NOVARTIS AG | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
University of Notre Dame | College/University | Undergraduate Degree Undergraduate Degree | |
BAYER AG | Pharmaceuticals: Major | Corporate Officer/Principal Sales & Marketing | |
PROCTER & GAMBLE COMPANY | Household/Personal Care | Comptroller/Controller/Auditor General Counsel | |
Shire Pharmaceuticals Ltd.
Shire Pharmaceuticals Ltd. BiotechnologyHealth Technology Part of Takeda Pharmaceutical Co., Ltd., Shire Pharmaceuticals Ltd. is a patient-focused, British innovation-driven pharmaceutical company. The company is based in London, UK. Takeda has a distinguished 240-year history and aspires to bring better health and a brighter future for people worldwide. Shire Pharmaceuticals was founded in 1986. The CEO is Flemming Ørnskov. | Biotechnology | Director/Board Member Chief Executive Officer | |
UNILEVER PLC | Household/Personal Care | Director/Board Member | |
Roche Innovation Center Copenhagen A/S
Roche Innovation Center Copenhagen A/S Pharmaceuticals: MajorHealth Technology Roche Innovation Center Copenhagen A/S discovers and develops drugs for the treatment of oncology, metabolic diseases, and infectious diseases. The firm manufactures a pipeline of drug candidates that act selectively on disease-related ribonucleic acid to provide patients with novel treatments for both rare and common diseases. It produces pre-clinical and clinical assets for the treatment of a range of diseases including oncology, metabolic diseases, and infectious diseases. The company was founded by Matts Lundwall and Mikael Ørum on January 1, 1998 and is headquartered in Horsholm, Denmark. | Pharmaceuticals: Major | Chairman | |
Algotherapeutix SAS
Algotherapeutix SAS Medical SpecialtiesHealth Technology AlgoTherapeutix SAS is a clinical-stage biotechnology company based in Suresnes, France. The French company is focused on developing targeted, first-in-class therapeutics for peripheral neuropathic pain. Its lead asset, ATX01, is a proprietary topical formulation of amitriptyline that targets the signaling pathways involved in the regulation of pain by inhibiting specific nociceptive sodium channel receptors. The company is currently recruiting patients for a phase II clinical trial of 240 patients for chemotherapy-induced neuropathic pain and a phase II proof of concept trial for erythromelalgia. AlgoTherapeutix has secured FDA fast track development status and orphan drug designation in both the US and EU. AlgoTherapeutix has raised EUR 35 million to date and has a consortium of investors, including Relyens Innovation Santé/Turenne Capital, UI Investissement, and angel investors. The company was founded in 2018 by Olivier Jean Bohuon and Stéphane Thiroloix, with Stéphane Thiroloix serving as the CEO since 2018. | Medical Specialties | Founder | |
Bankers Trust & Co.
Bankers Trust & Co. Investment Trusts/Mutual FundsMiscellaneous Part of Deutsche Bank AG, Bankers Trust & Co. is a company that provides trust services. The company is based in New York, NY. | Investment Trusts/Mutual Funds | Corporate Officer/Principal | |
Laboratoires Majorelle SAS
Laboratoires Majorelle SAS Medical DistributorsDistribution Services Laboratoires Majorelle SAS operates as an independent French pharmaceutical company. Its products include Vitaros, Optilov, Keat range, and Carmex. The company was founded by Guillaume El Glaoui in 2012 and is headquartered in Paris, France. | Medical Distributors | Chairman | |
Essex Woodlands Management, Inc.
Essex Woodlands Management, Inc. Investment ManagersFinance Essex Woodlands Management, Inc. (EW Healthcare Partners) is a private equity firm founded in 1985 by Jim L. Currie and Martin P. Sutter. The firm is headquartered in Houston, Texas. | Investment Managers | Consultant / Advisor | |
Majorelle Topco Ltd. | Director/Board Member | ||
VELOXIS PHARMACEUTICALS A/S | Pharmaceuticals: Major | Chief Executive Officer | |
Astion Pharma A/S
Astion Pharma A/S Pharmaceuticals: MajorHealth Technology Astion Pharma A/S develops and manufactures pharmaceutical products. It focuses on developing anti-inflammatory drugs for dermatological and immunological diseases. The company was founded by Morten S. Weidner in 1992 and is headquartered in Copenhagen, Denmark. | Pharmaceuticals: Major | Chairman | |
Yale School of Management | College/University | Masters Business Admin | |
EVOTEC SE | Pharmaceuticals: Major | Chairman | |
IKARIA, INC. | Biotechnology | Chief Executive Officer | |
COCA-COLA HELLENIC | Beverages: Non-Alcoholic | Director/Board Member | |
KEURIG GREEN MOUNTAIN INC | Food: Specialty/Candy | Director/Board Member | |
Merck & Co., Inc. /Cherokee Chemical Manufacturing Plant/ | Chemicals: Major Diversified | Corporate Officer/Principal | |
PCI BIOTECH HOLDING ASA | Biotechnology | Director/Board Member | |
Bausch & Lomb, Inc.
Bausch & Lomb, Inc. Medical SpecialtiesHealth Technology Bausch & Lomb, Inc. develops, manufactures, and markets eye health products. It offers over-the-counter supplements, eye care products, ophthalmic pharmaceuticals, contact lenses, lens care, ophthalmic surgical devices, and instruments. The company was founded by John Jacob Bausch and Henry Lomb in 1853 and is headquartered in Rochester, NY. | Medical Specialties | Corporate Officer/Principal | |
Credit Suisse Securities (Europe) Ltd.
Credit Suisse Securities (Europe) Ltd. Investment Banks/BrokersFinance Credit Suisse Securities (Europe) Ltd. (Credit Suisse Europe) is the Great Britain-based brokerage subsidiary of Credit Suisse Investment Holdings (UK), itself a subsidiary of Credit Suisse Group AG (SWX: CSGN) in Switzerland. The firm was founded in 1966 and formerly known as Credit Suisse First Boston (Europe) Ltd. Headquartered in London, Credit Suisse Europe arranges financing in international capital markets, provides financial advisory services and acts as a dealer in securities, derivatives and foreign exchange on a principal and agency basis for corporate and institutional investors. | Investment Banks/Brokers | Corporate Officer/Principal | |
SIGNATURE AVIATION | Other Transportation | Director/Board Member | |
Biotech Promise SCA SICAV-SIF | Director/Board Member | ||
OJB Conseil SAS | Chairman | ||
Académie des Technologies
Académie des Technologies Academie des Technologies engages in the technology industry. The company was founded in December 2000 and is headquartered in Paris, France. | Corporate Officer/Principal | ||
BHP GROUP LIMITED | Steel | Director/Board Member | |
The Takeover Panel | General Government | Corporate Officer/Principal | |
Siddhi Acquisition Corp.
Siddhi Acquisition Corp. Financial ConglomeratesFinance Siddhi Acquisition Corp. operates as a blank check company which was formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination. The company was founded by Brian D. Finn, Melissa Facchina and Steven Finn on August 27, 2020 and is headquartered in New York, NY. | Financial Conglomerates | Corporate Officer/Principal |
Statistics
International
United States | 19 |
United Kingdom | 9 |
Germany | 6 |
Switzerland | 5 |
France | 5 |
Sectoral
Health Technology | 23 |
Consumer Non-Durables | 7 |
Finance | 6 |
Commercial Services | 4 |
Consumer Services | 3 |
Operational
Director/Board Member | 149 |
Independent Dir/Board Member | 53 |
Corporate Officer/Principal | 47 |
Chairman | 44 |
Chief Executive Officer | 23 |
Most connected contacts
Insiders | |
---|---|
Steven Gillis | 58 |
Ian Clark | 36 |
Flemming Ørnskov | 35 |
Susan Kilsby | 24 |
Olivier Jean Bohuon | 24 |
S. Mathew | 18 |
Thomas Johannes W. Dittrich | 18 |
Gail Fosler | 16 |
Albert P. L. Stroucken | 11 |
Andreas Busch | 11 |
Abhinav Shukla | 9 |
Sun Kim | 6 |
Julie Person | 6 |
Bill Mordan | 6 |
William R. Mordan | 5 |
- Stock Market
- Insiders
- Paul Keogh
- Company connections